Does AZD-1222 Cause Muscular weakness? 377 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 377 reports of Muscular weakness have been filed in association with AZD-1222. This represents 16.1% of all adverse event reports for AZD-1222.
377
Reports of Muscular weakness with AZD-1222
16.1%
of all AZD-1222 reports
1
Deaths
109
Hospitalizations
How Dangerous Is Muscular weakness From AZD-1222?
Of the 377 reports, 1 (0.3%) resulted in death, 109 (28.9%) required hospitalization, and 90 (23.9%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 377 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Dyspnoea (472)
Abdominal discomfort (467)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which AZD-1222 Alternatives Have Lower Muscular weakness Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT